| Down-regulation of myogenin can reverse terminal muscle cell differentiation NP Mastroyiannopoulos, P Nicolaou, M Anayasa, JB Uney, LA Phylactou PloS one 7 (1), e29896, 2012 | 96 | 2012 |
| PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation V Chelban, MP Wilson, J Warman Chardon, J Vandrovcova, MN Zanetti, ... Annals of Neurology 86 (2), 225-240, 2019 | 67 | 2019 |
| Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X KA Kleopa, E Zamba-Papanicolaou, X Alevra, P Nicolaou, DM Georgiou, ... Neurology 66 (3), 396-402, 2006 | 61 | 2006 |
| Genomic and genetic studies of systemic sclerosis: A systematic review P Chairta, P Nicolaou, K Christodoulou Human Immunology 78 (2), 153-165, 2017 | 51 | 2017 |
| Twist induces reversal of myotube formation E Hjiantoniou, M Anayasa, P Nicolaou, I Bantounas, M Saito, S Iseki, ... Differentiation 76 (2), 182-192, 2008 | 47 | 2008 |
| A novel c. 5308_5311delGAGA mutation in Senataxin in a Cypriot family with an autosomal recessive cerebellar ataxia P Nicolaou, A Georghiou, C Votsi, LT Middleton, E Zamba-Papanicolaou, ... BMC Medical Genetics 9, 1-6, 2008 | 40 | 2008 |
| A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease P Nicolaou, C Cianchetti, A Minaidou, G Marrosu, E Zamba-Papanicolaou, ... European Journal of Human Genetics 21 (2), 190-194, 2013 | 36 | 2013 |
| Charcot-Marie-Tooth disease in Cyprus: epidemiological, clinical and genetic characteristics P Nicolaou, E Zamba-Papanicolaou, P Koutsou, KA Kleopa, A Georghiou, ... Neuroepidemiology 35 (3), 171-177, 2010 | 35 | 2010 |
| A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes KA Kleopa, DM Georgiou, P Nicolaou, P Koutsou, E Papathanasiou, ... Neurogenetics 5, 171-175, 2004 | 31 | 2004 |
| A novel CLN6 variant associated with juvenile neuronal ceroid lipofuscinosis in patients with absence of visual loss as a presenting feature P Nicolaou, GA Tanteles, C Votsi, E Zamba-Papanicolaou, ... Frontiers in genetics 12, 746101, 2021 | 14 | 2021 |
| Greek sage exhibits neuroprotective activity against amyloid beta-induced toxicity A Ververis, G Savvidou, K Ioannou, P Nicolaou, K Christodoulou, ... Evidence-Based Complementary and Alternative Medicine 2020, 2020 | 13 | 2020 |
| Genetic findings of Cypriot spinal muscular atrophy patients L Theodorou, P Nicolaou, P Koutsou, A Georghiou, V Anastasiadou, ... Neurological Sciences 36, 1829-1834, 2015 | 13 | 2015 |
| A novel SLC30A10 missense variant associated with parkinsonism and dystonia without hypermanganesemia S Lambrianides, P Nicolaou, M Michaelidou, P Kakouris, C Votsi, ... Journal of the Neurological Sciences 418, 2020 | 12 | 2020 |
| A novel GDAP1 mutation 439delA is associated with autosomal recessive CMT disease DM Georgiou, P Nicolaou, D Chitayat, P Koutsou, R Babul-Hirji, J Vajsar, ... Canadian journal of neurological sciences 33 (3), 311-316, 2006 | 8 | 2006 |
| Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches P Chairta, P Nicolaou, K Sokratous, C Galant, F Houssiau, A Oulas, ... Arthritis research & therapy 22, 1-9, 2020 | 6 | 2020 |
| Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis PP Chairta, P Nicolaou, K Christodoulou Scientific Reports 13 (1), 1934, 2023 | 4 | 2023 |
| LRSAM1 Depletion affects neuroblastoma SH-SY5Y cell growth and morphology: The LRSAM1 c. 2047-1G> A loss-of-function variant fails to rescue the phenotype A Minaidou, P Nicolaou, K Christodoulou Cell Journal (Yakhteh) 20 (3), 340, 2018 | 4 | 2018 |
| Advances in the molecular diagnosis of Charcot-Marie-Tooth disease P Nicolaou, K Christodoulou World Journal of Neurology 3 (3), 42-55, 2013 | 4 | 2013 |
| Deregulation of LRSAM1 expression impairs the levels of TSG101, UBE2N, VPS28, MDM2 and EGFR A Minaidou, P Nicolaou, K Christodoulou Plos one 14 (2), e0211814, 2019 | 3 | 2019 |
| The phenotypic spectrum of pathogenic ATP1A1 variants expands: the novel p. P600R substitution causes demyelinating Charcot-Marie-Tooth disease. C Yuksel F, P Nicolaou, K Spontarelli, MF Dohrn, AP Rebelo, P Koutsou, ... Journal of Neurology 270 (5), 2576-2590, 2023 | 2 | 2023 |
Kyproula ChristodoulouProfessor, The Cyprus Institute of Neurology and GeneticsVerified email at cing.ac.cy
